Overview of Biotech Capital Markets Through Week Ended March 3rd, 2023

Let's take a look at some highlights from the Biotech and MedTech/Diagnostics Private and Public Capital Markets and SPAC Activity Through the Week Ended March 3rd, 2023.

2023 YTD

• 31 Biotech transactions totaling just over $3.5 Billion v. 2022: 15 Biotech transactions totaling just over $1.9 Billion

• 6 Med Tech transactions totaling just over $400 Million v. 2022: 1 Med Tech transaction just under $30 Million

Week Ending March 3rd, 2023

• Biotech: 3 Transactions (3 Follow-Ons) totaling just over $600 Million

• Med Tech: No Current Week Transactions
  

Private Transactions

• Biotech: 39 US Transactions / 13 European Transaction

• Med Tech: 26 US Transactions / 6 European Transaction